Erythromycin - NDC Database (Page 2)
0093-5571 May 04, 2021
Erythromycin 250 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
Erythromycin 250 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
0093-5572 May 04, 2021
Erythromycin 500 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
Erythromycin 500 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
0168-0215 Sep 30, 1997
Erythromycin 20 mg/ml Topical Solution by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
Erythromycin 20 mg/ml Topical Solution by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
0168-0216 Sep 30, 1997
Erythromycin 20 mg/g Topical Gel by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
Erythromycin 20 mg/g Topical Gel by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
13668-586 Jul 26, 2021
Erythromycin 250 mg Oral Tablet, Delayed Release by Torrent Pharmaceuticals Limited
Erythromycin 250 mg Oral Tablet, Delayed Release by Torrent Pharmaceuticals Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.